Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

NCT02303041 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Business Decision

Conditions

Carcinoma, Basal Cell
Recurrent Skin Cancer
Skin Neoplasms
Basal Cell Nevus Syndrome

Interventions

DRUG: Buparlisib
DRUG: Sonidegib

Sponsor

Anne Chang

Collaborators

[object Object]